Share Buyback Programme

1 October 2026

McBride plc

Third tranche of share buyback programme

McBride plc (the “Company”), the leading European manufacturer and supplier of private label and contract manufactured products for the domestic household and professional cleaning/hygiene markets, today announces the commencement of the third tranche of its share buyback programme to purchase ordinary shares of 10 pence each in the Company (“Ordinary Shares”), as launched on 1 December 2025 (the “Programme”). 

Purchases under the first tranche of the Programme commenced on 1 December 2025 and continued until 30 April 2026. Purchases under the second tranche of the Programme commenced on 1 May 2026 and continued until 30 September 2026. Under the first and second tranches, the Company repurchased 5,159,388 Ordinary Shares for an aggregate consideration of approximately £7.5 million (excluding transaction costs).

The Company announces that the third tranche of the Programme, comprising purchases of Ordinary Shares for an aggregate consideration of up to £6,239,668, excluding transaction costs, will commence today (the “Third Tranche”). This represents half of the £12,479,336 remaining under the £20 million Programme following completion of the first and second tranches.

The Third Tranche is structured in two phases. In respect of the first phase, the Company has entered into a non-discretionary agreement with Investec Bank plc (“Investec”) to act as riskless principal in relation to the purchase of Ordinary Shares, and the subsequent sale of such Ordinary Shares to the Company. The second phase will be undertaken by Peel Hunt LLP (“Peel Hunt”, and together with Investec, the “Brokers”). The Company has entered into a separate non-discretionary agreement with Peel Hunt to act as riskless principal in relation to the purchase of Ordinary Shares, and the subsequent sale of such Ordinary Shares to the Company.

Purchases of Ordinary Shares under the Third Tranche are expected to commence on 1 October 2026 and to be completed by no later than 31 March 2027. The Company intends to announce any purchases under the Programme on a weekly basis from the commencement of the Third Tranche of the Programme.

The Brokers will each make trading decisions in relation to the Programme independently of the Company. Any purchase of Ordinary Shares by the Brokers contemplated by this announcement will be carried out on the London Stock Exchange.

The purpose of the Programme is to reduce the share capital of the Company by returning surplus capital to shareholders. Ordinary Shares purchased under the Third Tranche will be cancelled.  The Third Tranche will initially be conducted in accordance with and under the terms of the general authority granted by the Company’s shareholders at the Company's Annual General Meeting on 20 November 2025, which authority will expire at the close of business on 31 December 2026 or, if earlier, the conclusion of the Company’s next Annual General Meeting (the “2025 Authority”).  The maximum number of Ordinary Shares that may be purchased under the Third Tranche pursuant to the 2025 Authority is 12,242,140. Purchases effected following the expiry of the 2025 Authority will be conditional on the receipt of a similar shareholder authority being granted at the Company’s 2026 Annual General Meeting (the “2026 Authority”). The maximum number of Ordinary Shares that may be purchased under the Third Tranche pursuant to the 2026 Authority is half the number of shares which may be purchased under the 2026 Authority.

The Third Tranche will also be conducted within certain pre-set parameters, in accordance with Chapter 9 of the Listing Rules and within the parameters prescribed by the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation (EU) 2016/1052 (both as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

From time to time, the Board will assess the progress of this Programme in light of the financial situation of the Company and its capital allocation needs.

For further information, please contact: